The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,385.00
Bid: 2,380.00
Ask: 2,385.00
Change: -5.00 (-0.21%)
Spread: 5.00 (0.21%)
Open: 2,360.00
High: 2,395.00
Low: 2,360.00
Prev. Close: 2,390.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

18 Nov 2016 07:00

RNS Number : 5211P
Oxford Instruments PLC
18 November 2016
 

Release date: 18 November 2016

Oxford Instruments plc

Disposal of Oxford Instruments Superconducting Wire LLC ("OST")

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the disposal of Oxford Instruments Superconducting Wire LLC ("OST") to Bruker Energy and Supercon Technologies Inc ("BEST"), a subsidiary of Bruker Corporation, for a consideration of $17.5 million, payable in cash. In the transaction, BEST has acquired the entire share capital of OST from Oxford Instruments.

 

OST supplies world-leading superconducting wire for use in MRI scanners and other medical and scientific applications; it is located in Carteret, New Jersey, USA. The business was previously part of Oxford Instruments' Industrial Products division.

 

In the year ended 31 March 2016, OST had revenues of £42.4 million and achieved an operating profit of £3.4 million. In the six months to 30 September 2016, OST had revenues of £19.1 million and achieved an operating profit of £1.1 million. The gross assets of OST at 31 March 2016 were £19.0 million.

Oxford Instruments has previously reported challenges within the superconducting wire markets due primarily to pricing pressures exerted by the MRI system manufacturers and reduced demand for wire from OEM customers. The disposal represents a further step in the Group's strategy of actively managing its portfolio.

Ian Barkshire, Chief Executive of Oxford Instruments said "After a comprehensive review of our portfolio, the Board has determined that our Superconducting Wire business is no longer core to the Group's long-term strategic vision. The divestment will allow increased focus across the Group on our chosen market segments and the cash proceeds will enable us to reduce our net debt, in line with our strategy to deliver enhanced shareholder value.

"OST is a high quality business and we believe that as part of BEST, it will benefit from the realisation of synergies and the scale of BEST's expertise in low-temperature superconductors. This will ensure that the business continues to provide customers with the highest quality products and fosters the exceptional skills of its talented workforce."

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Jamie Ricketts

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

 

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

 

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISDXBDBDXBBGLR
Date   Source Headline
8th Jun 20217:00 amRNSPreliminary Results
3rd Jun 202112:49 pmPRNTotal Voting Rights
11th May 20212:13 pmPRNDirector/PDMR Shareholding
22nd Apr 20219:50 amPRNDirector/PDMR Shareholding
6th Apr 20213:43 pmPRNHolding(s) in Company
26th Mar 20217:00 amRNSTrading Update
11th Mar 20215:05 pmPRNDirector/PDMR Shareholding
10th Mar 20219:12 amPRNHolding(s) in Company
4th Mar 20214:48 pmPRNHolding(s) in Company
11th Feb 20214:24 pmPRNHolding(s) in Company
11th Feb 20211:26 pmPRNDirector/PDMR Shareholding
4th Feb 20214:42 pmPRNHolding(s) in Company
27th Jan 20218:00 amPRNDirectorate Change
12th Jan 202110:56 amPRNDirector/PDMR Shareholding
7th Jan 20214:09 pmPRNTotal Voting Rights
7th Jan 20213:29 pmPRNBlocklisting - Interim Review
11th Dec 202011:27 amPRNDirector/PDMR Shareholding
3rd Dec 20201:22 pmPRNTotal Voting Rights
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
17th Nov 202010:51 amPRNDirector/PDMR Shareholding-2nd amendment
17th Nov 202010:35 amPRNDirector/PDMR Shareholding - amendment
17th Nov 20208:58 amPRNDirector/PDMR Shareholding
12th Nov 20203:04 pmPRNDirector/PDMR Shareholding
10th Nov 20207:00 amRNSHalf-year results
15th Oct 202010:20 amPRNHolding(s) in Company
14th Oct 20201:29 pmPRNDirector/PDMR Shareholding
8th Oct 20204:04 pmPRNTotal Voting Rights
24th Sep 202010:33 amPRNDirector/PDMR Shareholding
14th Sep 202012:52 pmPRNHolding(s) in Company
10th Sep 20204:31 pmPRNDirector/PDMR Shareholding
8th Sep 20202:58 pmPRNTotal Voting Rights
8th Sep 20202:48 pmPRNResult of AGM
8th Sep 20207:00 amRNSChairman’s AGM Statement 2020
7th Sep 202012:27 pmPRNHolding(s) in Company
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
26th Aug 202012:02 pmRNSPrice Monitoring Extension
25th Aug 202012:02 pmRNSPrice Monitoring Extension
20th Aug 202012:02 pmRNSPrice Monitoring Extension
19th Aug 202012:02 pmRNSPrice Monitoring Extension
18th Aug 202012:03 pmRNSPrice Monitoring Extension
11th Aug 202010:05 amPRNAdditional Listing
11th Aug 20209:51 amPRNDirector/PDMR Shareholding
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
6th Aug 202012:07 pmRNSSecond Price Monitoring Extn
6th Aug 202012:02 pmRNSPrice Monitoring Extension
3rd Aug 202012:07 pmRNSSecond Price Monitoring Extn
3rd Aug 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.